UNSPSC 85694918: Revision of autologous tissue substitute in right thumb phalanx, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right thumb phalanx, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PWR37Z

UNSPSC 85694918 Revision of autologous tissue substitute in right thumb phalanx, percutaneous approach is a Commodity code that does not align with the state and local contract opportunities posted under it. The recent solicitations recorded under this code span independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, surgical benefit carve-outs, temporary health professional staffing, and emergency medical services for detained youth — none of which involve tissue substitutes, hand procedures, or percutaneous surgical revision. The code's technical medical scope and the actual procurement activity tracked under it diverge substantially, suggesting a data-entry misalignment in the state and local procurement systems rather than a meaningful purchasing category.

The issuing bodies posting opportunities tagged to this code include city retirement offices (Phoenix), city benefits and procurement departments (Long Beach), state transportation departments (Washington), county juvenile probation departments (Harris County), county health systems (Santa Clara County Health System), and county commissioners' offices (Collier County). Geographic activity spans Arizona, California, Washington, Texas, and Florida. Given the disconnect between the code's stated scope and the medical services, staffing, and benefits-management work actually being solicited, procurement professionals should treat this code as currently misclassified rather than pursue opportunities tagged to it on the assumption of alignment with the tissue-substitute nomenclature.